ADA Scientific Sessions 2026 Abstract
BGE-102, a Novel NLRP3 Inhibitor, Demonstrated Robust Anti-Inflammatory Activity in an Ongoing Phase 1 Study in Healthy Volunteers and Participants with Obesity
Trial in peopleInterventions
Papers by Kevin Wilhelmsen
1 result